Abstract
Purpose
This study investigated the cytokine profile in bladder tissue and urine of painful bladder syndrome/interstitial cystitis (PBS/IC) patients.
Methods
Multiplex analysis of 23 cytokines was performed with a multiple antigen bead assay (Luminex 100 IS) on cold cup bladder biopsy and urine specimens collected during cystoscopy with hydrodistention (HD) under general anesthesia from 10 PBS/IC patients (ICS definition). Collected tissue specimens and urine from pre-HD and post-HD (mean 27 days) were compared to banked urine and tissue specimens (n = 10) collected from control subjects without PBS/IC symptoms.
Results
Univariate comparison of bladder tissue levels found significant elevation of IL-16, IL-18, CTACK, ICAM-1, MCP-3, SCGFβ, TRAIL, and VCAM-1 in PBS/IC relative to controls. Multivariate analysis revealed VCAM-1 and ICAM-1 were responsible for the discrimination of both tissue and urine of PBS/IC from controls. Urine levels of MCP-3 and TRAIL were significantly reduced a month after HD in concert with improvement in standardized measures of clinical symptoms (pain, urgency, and frequency (PUF) overall score [mean 25.8 ± 5.5 vs. 20.3 ± 7, p = 0.04] and symptom score [mean 18.2 ± 3.2 vs. 12.2 ± 5.9; p = 0.009]). Post-HD urine levels of MCSF(r = 0.88; p = 0.003), MCP-3 (r = 0.81; p = 0.01), SDF1α (r = 0.82; p = 0.01), and IL-18 (r = 0.64; p = 0.08) positively correlated with improved symptom scores.
Conclusions
These results indicate significant elevation of cytokines in PBS/IC bladder tissue relative to controls. Significant reduction in post-HD urine levels of MCP-3 and TRAIL relative to pre-HD in PBS/IC was associated with clinical improvement (as measured by PBS/IC symptom scores) to qualify them as biomarker candidates.
Similar content being viewed by others
References
Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM et al (2002) A comparison of multiple urine markers for interstitial cystitis. J Urol 167:2461–2469
Ogawa T, Homma T, Igawa Y, Seki S, Ishizuka O, Imamura T et al (2010) CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis. J Urol 183:1206–1212
Brewer ME, White WM, Klein FA, Klein LM, Waters WB (2007) Validity of pelvic pain, urgency, and frequency questionnaire in patients with interstitial cystitis/painful bladder syndrome. Urology 70:646–649
Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y et al (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42:629–635
George SK, Dipu MT, Mehra UR, Singh P, Verma AK, Ramgaokar JS (2006) Improved HPLC method for the simultaneous determination of allantoin, uric acid and creatinine in cattle urine. J Chromatogr, B: Anal Technol Biomed Life Sci 832:134–137
Smaldone MC, Vodovotz Y, Tyagi V, Barclay D, Philips BJ, Yoshimura N et al (2009) Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis. Urology 73:421–426
Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, Kalos M et al (2008) High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233:1171–1180
Bouchelouche K, Alvarez S, Andersen L, Nordling J, Horn T, Bouchelouche P (2004) Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells. J Urol 171:462–466
Tyagi P, Killinger K, Tyagi V, Nirmal J, Peters K (2012) Urinary chemokines as Non-Invasive predictors of Ulcerative interstitial cystitis. J Urol 187:1275–1279
Malaviya R, Ikeda T, Ross E, Abraham SN (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77–80
Dodd LG, Tello J (1998) Cytologic examination of urine from patients with interstitial cystitis. Acta Cytol 42:923–927
Kutlu O, Akkaya E, Koksal IT, Bassorgun IC, Ciftcioglu MA, Sanlioglu S et al (2010) Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis. Int Urol Nephrol 42:393–399
Wei W, Wang D, Shi J, Xiang Y, Zhang Y, Liu S et al (2010) Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migration of monocytes via a death receptor 4-mediated RhoGTPase pathway. Mol Immunol 47:2475–2484
McGrath EE, Marriott HM, Lawrie A, Francis SE, Sabroe I, Renshaw SA et al (2011) TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J Leukoc Biol 90:855–865
Rosevear HM, Lightfoot AJ, O’Donnell MA, Griffith TS (2009) The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guerin (BCG) immunotherapy for urothelial carcinoma of the bladder. Cancer Metastasis Rev 28:345–353
Ottem DP, Teichman JM (2005) What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology 66:494–499
Chai TC, Zhang CO, Shoenfelt JL, Johnson HW Jr, Warren JW, Keay S (2000) Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J Urol 163:1440–1444
Liu HT, Tyagi P, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int 104:1476–1481
Acknowledgments
This study was supported by the Samuel Wilan Research Fund for Interstitial Cystitis, NIH grants (DK57267 and DK88836) and Department of Defense grant PR110326.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Corcoran, A.T., Yoshimura, N., Tyagi, V. et al. Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens. World J Urol 31, 241–246 (2013). https://doi.org/10.1007/s00345-012-0852-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-012-0852-y